Related Experiment Videos
Two significant aspects of microcystin-LR: specific binding and liver specificity
R Nishiwaki1, T Ohta, E Sueoka
1Saitama Cancer Center Research Institute, Japan.
Cancer Letters
|August 15, 1994
Summary
Microcystin-LR, a potent liver tumor promoter, shows higher liver specificity than okadaic acid. Its uptake mechanisms differ significantly between intraperitoneal and oral administration routes.
Area of Science:
- Toxicology
- Hepatology
- Pharmacology
Background:
- Microcystin-LR is a potent liver tumor promoter and inhibitor of protein phosphatases 1 and 2A.
- It exhibits liver specificity, distinguishing it from similar okadaic acid class compounds.
Purpose of the Study:
- To investigate the specific binding and liver specificity of [3H]dihydromicrocystin-LR.
- To compare these properties with [3H]okadaic acid.
Main Methods:
- Studied specific binding of radiolabeled dihydromicrocystin-LR and okadaic acid in rat liver and tissue fractions.
- Administered [3H]dihydromicrocystin-LR intraperitoneally and orally to mice to assess liver uptake.
Main Results:
- [3H]-Dihydromicrocystin-LR demonstrated higher receptor affinity in rat liver and tissue fractions compared to [3H]okadaic acid.
- Intraperitoneal administration of [3H]dihydromicrocystin-LR resulted in high liver uptake (71.5%), while oral administration showed less than 1% uptake.
- Associated forms of [3H]dihydromicrocystin-LR were found with liver macromolecules.
Conclusions:
- Microcystin-LR possesses distinct liver-specific binding characteristics compared to okadaic acid.
- The route of administration significantly impacts microcystin-LR's liver incorporation, suggesting different uptake mechanisms.
- Further research is warranted to understand the association of microcystin-LR with liver macromolecules.